Similar articles

• Anthrax: clinical features, pathogenesis, and potential biological warfare threat.

  Friedlander AM. Friedlander AM. Curr Clin Top Infect Dis. 2000;20:335-49. Curr Clin Top Infect Dis. 2000. PMID: 10943532 Review. No abstract available.
• [Current status of anthrax or black fever].

  Chantal J. Chantal J. Med Trop (Mars). 1997;57(3 Suppl):52-60. Med Trop (Mars). 1997. PMID: 9513179 Review. French.
• [Anthrax--an old disease becomes topical: cutaneous anthrax and the eye].

  Kalpadakis P, Rudolph G, Stefani FH, Kampik A. Kalpadakis P, et al. Ophthalmologe. 2003 Mar;100(3):216-21. doi: 10.1007/s00347-002-0726-6. Ophthalmologe. 2003. PMID: 12640551 Review. German.
• [Anthrax].

  Makino S. Makino S. Chudoku Kenkyu. 2002 Apr;15(2):121-7. Chudoku Kenkyu. 2002. PMID: 12108013 Review. Japanese. No abstract available.
• Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.

  Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG. Tournier JN, et al. Expert Rev Anti Infect Ther. 2009 Mar;7(2):219-36. doi: 10.1586/14787210.7.2.219. Expert Rev Anti Infect Ther. 2009. PMID: 19254170 Review.